Calibrated company-line yield modeling for ABT, BSX, and MDT.
The Hybrid mode estimates line yield from category complexity, annual implant volume, and manufacturer portfolio mix. It is anchored for realistic CRM ranges: ICD around 90% and top pacemaker lines near 98%.
ABT, BSX, MDT
Pacemaker, ICD, CRT-D, CRT-P, TPS
Deterministic calibrated hybrid scoring
| Tool | Description | Parameters |
|---|---|---|
| predict_hybrid_yield_by_company_line | Predict yield for a single company + category line. | company, device_category, year, maturity_bonus |
| rank_hybrid_lines | Rank company-category lines by estimated yield. | year, top_n, company, maturity_bonus |
Outputs are clipped to realistic manufacturing bounds for this domain.